Quick Answer
Lantern Pharma Inc. reported Shares Outstanding of 11.25 million shares for fiscal year 2025.
Lantern Pharma Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 11.25M | +4.4% |
| 2024 | 10.78M | +0.6% |
| 2023 | 10.72M | -1.3% |
| 2022 | 10.86M | -2.1% |
| 2021 | 11.09M | +78.3% |
| 2020 | 6.22M | +214.5% |
| 2019 | 1.98M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 11.04M | +2.4% | +2.4% |
| June 30, 2025 | 10.78M | +0.2% | +0.0% |
| March 31, 2025 | 10.78M | +0.2% | +0.0% |
| December 31, 2024 | 10.78M | +0.6% | +0.0% |
| September 30, 2024 | 10.78M | -0.8% | +0.2% |
| June 30, 2024 | 10.76M | -1.0% | +0.0% |
| March 31, 2024 | 10.76M | -0.9% | +0.4% |
| December 31, 2023 | 10.72M | -1.3% | -1.4% |
- Lantern Pharma Inc. showed an increase of +4.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, Lantern Pharma Inc.’s shares outstanding has grown by 468.9% (from 1.98 million shares to 11.25 million shares).
- The most recent figure is from Lantern Pharma Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: